XML 38 R8.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Operating Activities    
Net income $ 418,542 $ 24,991
Adjustments to reconcile net income to cash provided by operating activities:    
Depreciation and amortization 254,854 221,016
Amortization of upfront incentive consideration 31,575 33,177
Litigation-related (credits) charges (49,194) (6,132)
Stock-based compensation expense 23,328 13,849
Allowance for doubtful accounts 6,745 5,916
Deferred income taxes 63,402 34,952
Joint venture equity income (14,198) (9,367)
Dividends received from joint venture investments 28,700 2,205
Amortization of debt issuance costs 4,893 4,779
Gain on remeasurement of previously-held joint venture interest (86,082) 0
Loss on extinguishment of debt 33,235 33,538
Other 10,730 1,880
(Income) loss from discontinued operations (213,499) 44,652
Changes in operating assets and liabilities:    
Accounts and other receivables (64,296) (72,559)
Prepaid expenses and other current assets 5,249 3,721
Capitalized implementation costs (49,642) (27,091)
Upfront incentive consideration (46,409) (31,633)
Other assets (55,439) (60,526)
Accrued compensation and related benefits 10,294 (5,752)
Accounts payable and other accrued liabilities 60,554 29,654
Deferred revenue including upfront solution fees 16,368 44,274
Cash provided by operating activities 389,710 285,544
Investing Activities    
Additions to property and equipment (203,071) (154,212)
Acquisitions, net of cash acquired (441,582) (31,799)
Other investing activities 148 234
Cash used in investing activities (644,505) (185,777)
Financing Activities    
Proceeds of borrowings from lenders 752,000 148,307
Payments on borrowings from lenders (719,507) (797,028)
Debt prepayment fees and issuance costs (40,214) (30,490)
Acquisition-related contingent consideration paid 0 (27,000)
Proceeds from issuance of common stock in initial public offering, net 0 672,137
Net proceeds on the settlement of equity-based awards 40,045 2,376
Cash dividends paid to common stockholders (73,554) (23,831)
Other financing activities 1,975 (3,755)
Cash used in financing activities (39,255) (59,284)
Cash Flows from Discontinued Operations    
Cash used in operating activities (908) (189,802)
Cash provided by (used in) investing activities 278,834 (1,904)
Cash provided by (used in) discontinued operations 277,926 (191,706)
Effect of exchange rate changes on cash and cash equivalents (6,860) 734
Decrease in cash and cash equivalents (22,984) (150,489)
Cash and cash equivalents at beginning of period 155,679 308,236
Cash and cash equivalents at end of period $ 132,695 $ 157,747